Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
151 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06031493 | A Multimodal Intervention Program to Improve Sexual Health and Self-perceived Quality of Life in Patients Treated for Cervical Cancer (PROVIDENCE)(PROVIDENCE) | unknown | Phase 4 | 122 | Hospital Clinic of BarcelonaOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT01735955 | Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study | completed | Phase 4 | 57 | Novartis PharmaceuticalsINDUSTRY | 16 | Feb 8, 2024 |
| clinicaltrials |
| NCT03677596 | A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients | completed | Phase 4 | 102 | PfizerINDUSTRY | 8 | Nov 22, 2023 | clinicaltrials |
| NCT06055543 | Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients | unknown | Phase 4 | 140 | Danone Specialized NutritionINDUSTRY | 1 | Sep 26, 2023 | clinicaltrials |
| NCT01995513 | Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients(PLATO) | completed | Phase 4 | 509 | PfizerINDUSTRY | 11 | Sep 18, 2023 | clinicaltrials |
| NCT02869789 | An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers | completed | Phase 4 | 1,041 | Bristol-Myers SquibbINDUSTRY | 21 | Jun 15, 2023 | clinicaltrials |
| NCT00128297 | Pamidronate Administration in Breast Cancer Patients With Bone Metastases | completed | Phase 4 | 152 | Spanish Breast Cancer Research GroupOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT01298193 | Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer. | completed | Phase 4 | 212 | Spanish Breast Cancer Research GroupOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT00128778 | Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer Patients | completed | Phase 4 | 288 | Spanish Breast Cancer Research GroupOTHER | 1 | Mar 6, 2023 | clinicaltrials |
| NCT04875026 | Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial | completed | Phase 4 | 146 | Pierre Fabre MedicamentINDUSTRY | 4 | Sep 19, 2022 | clinicaltrials |
| NCT02476968 | To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer(ORZORA) | completed | Phase 4 | 181 | AstraZenecaINDUSTRY | 8 | Sep 10, 2022 | clinicaltrials |
| NCT04297423 | Two Low Volume Regimens for Colorectal Cancer Screening Colonoscopy(LOWOL) | completed | Phase 4 | 1,002 | Hospital Clinic of BarcelonaOTHER | 1 | Sep 9, 2022 | clinicaltrials |
| NCT03333655 | Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy | completed | Phase 4 | 15 | Hoffmann-La RocheINDUSTRY | 5 | Aug 12, 2022 | clinicaltrials |
| NCT04197089 | Biological Effect of Vitamin D in Patients With Urothelial Carcinoma(VitDURO) | completed | Phase 4 | 2 | Germans Trias i Pujol HospitalOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT05404243 | Clinical Trial to Test the Phenolization in Sacrococcygeal Pilonidal Disease(SPQF) | completed | Phase 4 | 122 | HJ23INDUSTRY | 1 | Jun 7, 2022 | clinicaltrials |
| NCT05340634 | Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS. | completed | Phase 4 | 90 | Margan BiotechINDUSTRY | 1 | Apr 28, 2022 | clinicaltrials |
| NCT05191225 | Ultrafast Truxima Infusion in Non-Hodgkin's Lymphoma: Txagorapid Study | unknown | Phase 4 | 48 | Laida Cuevas PalomaresNETWORK | 1 | Mar 31, 2022 | clinicaltrials |
| NCT03727750 | Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML | completed | Phase 4 | 51 | PfizerINDUSTRY | 6 | Mar 25, 2022 | clinicaltrials |
| NCT04705883 | Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors(VIBRA) | completed | Phase 4 | 10 | Hospital Clinic of BarcelonaOTHER | 1 | Feb 22, 2022 | clinicaltrials |
| NCT01358201 | PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years | unknown | Phase 4 | 100 | PETHEMA FoundationOTHER | 1 | Jan 19, 2022 | clinicaltrials |
| NCT01366898 | Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years) | unknown | Phase 4 | 100 | PETHEMA FoundationOTHER | 1 | Jan 19, 2022 | clinicaltrials |
| NCT01491763 | Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE | unknown | Phase 4 | 70 | PETHEMA FoundationOTHER | 1 | Jan 19, 2022 | clinicaltrials |
| NCT03937583 | Screening for Cancer in Patients With Unprovoked VTE(SOME-RIETE) | unknown | Phase 4 | 650 | Fundación Pública Andaluza para la gestión de la Investigación en SevillaOTHER | 1 | Dec 9, 2021 | clinicaltrials |
| NCT02092467 | Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | completed | Phase 4 | 4,372 | PfizerINDUSTRY | 30 | Aug 17, 2021 | clinicaltrials |
| NCT01789281 | Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. | completed | Phase 4 | 34 | Novartis PharmaceuticalsINDUSTRY | 9 | Jun 11, 2021 | clinicaltrials |
| NCT01990534 | A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma | completed | Phase 4 | 60 | Millennium Pharmaceuticals, Inc.INDUSTRY | 7 | Apr 9, 2021 | clinicaltrials |
| NCT02015923 | Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases(CCRe-IV) | terminated | Phase 4 | 107 | Hospital Universitari de BellvitgeOTHER | 1 | Mar 16, 2021 | clinicaltrials |
| NCT00380874 | Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer | terminated | Phase 4 | 64 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc.INDUSTRY | 6 | Feb 11, 2021 | clinicaltrials |
| NCT00381095 | A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer(COPE) | terminated | Phase 4 | 152 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc.INDUSTRY | 19 | Jan 20, 2021 | clinicaltrials |
| NCT01739764 | An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol | completed | Phase 4 | 215 | Hoffmann-La RocheINDUSTRY | 25 | Jan 7, 2021 | clinicaltrials |
| NCT01588184 | An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study | completed | Phase 4 | 95 | Hoffmann-La RocheINDUSTRY | 21 | Nov 5, 2020 | clinicaltrials |
| NCT03733639 | Tisseel® as a Reinforcement of Esophagojejunal Anastomoses | unknown | Phase 4 | 146 | Germans Trias i Pujol HospitalOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT00853008 | Treatment of High Risk Adult Acute Lymphoblastic Leukemia(LAL-AR/2003) | completed | Phase 4 | 100 | PETHEMA FoundationOTHER | 1 | Apr 7, 2020 | clinicaltrials |
| NCT01087008 | Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse(AZABACHE) | completed | Phase 4 | 103 | PETHEMA FoundationOTHER | 1 | Apr 6, 2020 | clinicaltrials |
| NCT02036489 | Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia | completed | Phase 4 | 107 | PETHEMA FoundationOTHER | 1 | Mar 5, 2020 | clinicaltrials |
| NCT04261179 | Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer(SENTINELSEEK) | unknown | Phase 4 | 30 | Anna CrucetaOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT02773550 | Treatment With a Scheme With Low Doses of Bortezomib / Melphalan / Prednisone (MPV) in Patients With Multiple Myeloma(Velcadito) | terminated | Phase 4 | 24 | Basque Health ServiceOTHER_GOV | 1 | Jan 18, 2020 | clinicaltrials |
| NCT01578213 | Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients(ISAV) | completed | Phase 4 | 112 | University of Milano BicoccaOTHER | 5 | Dec 3, 2019 | clinicaltrials |
| NCT00858754 | Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects | withdrawn | Phase 4 | 0 | Bausch Health Americas, Inc.INDUSTRY | 4 | Nov 29, 2019 | clinicaltrials |
| NCT01525550 | A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors | completed | Phase 4 | 106 | PfizerINDUSTRY | 15 | Jul 30, 2019 | clinicaltrials |
| NCT02261896 | Antibiotic Prophylaxis for Endoscopic Ultrasound Guided Fine Needle Aspiration of Pancreatic Cystic Lesions | completed | Phase 4 | 226 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | Apr 12, 2019 | clinicaltrials |
| NCT02785822 | Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle. | terminated | Phase 4 | 19 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT03811509 | Breast Cancer Women on Aromatase Inhibitors Treatment(B-ABLE) | unknown | Phase 4 | 1,000 | Parc de Salut MarOTHER | 1 | Jan 28, 2019 | clinicaltrials |
| NCT01493713 | Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer(AVAMET) | completed | Phase 4 | 83 | Grupo Espanol Multidisciplinario del Cancer DigestivoOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT02909049 | Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy | completed | Phase 4 | 100 | Complexo Hospitalario Universitario de A CoruñaOTHER | 1 | Jan 26, 2018 | clinicaltrials |
| NCT01768988 | Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study(PANPAIN/1) | terminated | Phase 4 | 20 | Parc de Salut MarOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT00430352 | MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma. | completed | Phase 4 | 545 | Hoffmann-La RocheINDUSTRY | 24 | Aug 14, 2017 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials